Research programme: rotavirus vaccines - Sanofi Pasteur
Latest Information Update: 28 Aug 2024
At a glance
- Originator Sanofi Pasteur
- Developer Sanofi
- Class Rotavirus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Rotavirus infections
Most Recent Events
- 28 Aug 2024 No recent reports of development identified for research development in Rotavirus-infections(Prevention) in France
- 28 Jul 2020 Sanofi in-licenses rotavirus vaccine technology from Xiamen Innovax Biotech
- 28 Jul 2020 Early research in Rotavirus infections (Prevention) in France (Unspecified)